Author/Authors :
Al Ghonaim, Mohammed King Saud University - King Khalid University Hospital - Department of Medicine,Section of Nephrology, Saudi Arabia , Habib-ur-Rahman King Saud University - King Khalid University Hospital - Department of Medicine,Section of Nephrology, Saudi Arabia , Al Suwaida, Abdulkareem King Saud University - King Khalid University Hospital - Department of Medicine,Section of Nephrology, Saudi Arabia , Askar, Akram King Saud University - King Khalid University Hospital, - Department of Medicine,Section of Nephrology, Saudi Arabia , Imtiaz, Salman King Saud University - King Khalid University Hospital, - Department of Medicine,Section of Nephrology, Saudi Arabia , Al-Wakeel, Jamal S King Saud University - King Khalid University Hospital - Department of Medicine,Section of Nephrology, Saudi Arabia
Abstract :
Kidney transplant is the best way of treating the end stage renal disease patients, but prolonged and heavy immunosuppressive therapy expose them for other complications, one of them is the increase risk of malignancy.
Keywords :
Kidney transplant , Malignancy , Immunosuppression , Transitional cell carcinoma
